Aligos Therapeutics, Inc.
Aligos Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California. They are focused on developing best-in-class therapies for liver and viral diseases, specifically targeting areas with high unmet medical needs. Their pipeline includes treatments for chronic HBV infection and MASH. Aligos aims to significantly improve patient outcomes through science-driven approaches and a patient-centric focus.
Offizielles Register
KI-Qualitätsanalyse
Vertrauensscore-Details
Schnellzugriff
Website-Highlights
🌟 Ähnliche vertrauenswürdige Unternehmen
Metagenomi, Inc.
Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.
ARCTICZYMES TECHNOLOGIES ASA
ArcticZymes Technologies ist ein Biotechnologieunternehmen, das sich auf die Entwicklung und Produktion von Enzymen spezialisiert hat. Sie bieten Nukleasen für die Bioproduktion und molekulare Diagnostik an, darunter salzaktive Nukleasen (SAN). Das Unternehmen ist bekannt für seine Polymerasen und Enzyme, die in Forschungs- und Industrieanwendungen eingesetzt werden.
ACD PHARMACEUTICALS AS
ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.